Recent News

• 06.09.2025 - Beth Lang
• 06.09.2025 - Beth Lang
• 06.09.2025 - Beth Lang
• 06.04.2025 - Jefferies Global Healthcare Conference
• 06.04.2025 - Jefferies Global Healthcare Conference
• 06.04.2025 - Jefferies Global Healthcare Conference
• 06.02.2025 - Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD
• 06.02.2025 - Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD
• 06.02.2025 - Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD
• 06.02.2025 - Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD

Recent Filings

• 06.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.03.2025 - 4 Statement of changes in beneficial ownership of securities